References
1. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically
ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a
single-centered, retrospective, observational study. The Lancet
Respiratory Medicine . 2020;8(5):475-481.
doi:10.1016/S2213-2600(20)30079-5
2. Gibson PG, Qin L, Puah SH. COVID‐19 acute respiratory distress
syndrome (ARDS): clinical features and differences from typical
pre‐COVID‐19 ARDS. Med J Aust . Published online June 22, 2020.
doi:10.5694/mja2.50674
3. The ARDS Definition Task Force*. Acute Respiratory Distress Syndrome:
The Berlin Definition. JAMA . 2012;307(23):2526-2533.
doi:10.1001/jama.2012.5669
4. Kalil AC, Thomas PG. Influenza virus-related critical illness:
pathophysiology and epidemiology. Critical Care . 2019;23(1):258.
doi:10.1186/s13054-019-2539-x
5. Rozencwajg S, Bréchot N, Schmidt M, et al. Co-infection with
influenza-associated acute respiratory distress syndrome requiring
extracorporeal membrane oxygenation. Int J Antimicrob Agents .
2018;51(3):427-433. doi:10.1016/j.ijantimicag.2017.11.005
6. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of
COVID-19-associated acute respiratory distress syndrome: a multicentre
prospective observational study. The Lancet Respiratory Medicine .
Published online August 2020:S2213260020303702.
doi:10.1016/S2213-2600(20)30370-2
7. Bartlett RH, Ogino MT, Brodie D, et al. Initial ELSO Guidance
Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary
Failure. ASAIO J . 2020;66(5):472-474.
doi:10.1097/MAT.0000000000001173
8. Clinical management of COVID-19. Accessed November 12, 2020.
https://www.who.int/publications-detail-redirect/clinical-management-of-covid-19
9. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign:
guidelines on the management of critically ill adults with Coronavirus
Disease 2019 (COVID-19). Intensive Care Med . Published online
March 28, 2020:1-34. doi:10.1007/s00134-020-06022-5
10. Savarimuthu S, BinSaeid J, Harky A. The role of ECMO in COVID‐19:
Can it provide rescue therapy in those who are critically ill?Journal of Cardiac Surgery . 2020;35(6):1298-1301.
doi:10.1111/jocs.14635
11. Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca
J. Extracorporeal Membrane Oxygenation for Treating Severe Cardiac and
Respiratory Disease in Adults: Part 1—Overview of Extracorporeal
Membrane Oxygenation. Journal of Cardiothoracic and Vascular
Anesthesia . 2009;23(6):886-892. doi:10.1053/j.jvca.2009.08.006
12. Ratnani I, Tuazon D, Zainab A, Uddin F. The Role and Impact of
Extracorporeal Membrane Oxygenation in Critical Care. Methodist
Debakey Cardiovasc J . 2018;14(2):110-119. doi:10.14797/mdcj-14-2-110
13. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous
extracorporeal membrane oxygenation for acute respiratory distress
syndrome: a systematic review and meta-analysis. Lancet Respir
Med . 2019;7(2):163-172. doi:10.1016/S2213-2600(18)30452-1
14. Brodie D, Bacchetta M. Extracorporeal Membrane Oxygenation for ARDS
in Adults. New England Journal of Medicine .
2011;365(20):1905-1914. doi:10.1056/NEJMct1103720
15. Combes A, Hajage D, Capellier G, et al. Extracorporeal Membrane
Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl
J Med . 2018;378(21):1965-1975. doi:10.1056/NEJMoa1800385
16. Schmidt M, Pham T, Arcadipane A, et al. Mechanical Ventilation
Management during Extracorporeal Membrane Oxygenation for Acute
Respiratory Distress Syndrome. An International Multicenter Prospective
Cohort. Am J Respir Crit Care Med . 2019;200(8):1002-1012.
doi:10.1164/rccm.201806-1094OC
17. Sukhal S, Sethi J, Ganesh M, Villablanca PA, Malhotra AK,
Ramakrishna H. Extracorporeal Membrane Oxygenation in Severe Influenza
Infection with Respiratory Failure: A Systematic Review and
Meta-analysis. Ann Card Anaesth . 2017;20(1):14-21.
doi:10.4103/0971-9784.197820
18. Bagga S, Paluzzi DE, Chen CY, et al. Better Ventilator Settings
Using a Computerized Clinical Tool. Respiratory Care .
2014;59(8):1172-1177. doi:10.4187/respcare.02223
19. Hsu J, Santesso N, Mustafa R, et al. Antivirals for Treatment of
Influenza. Ann Intern Med . 2012;156(7):512-524.
doi:10.7326/0003-4819-156-7-201204030-00411
20. The effect of corticosteroids on mortality of patients with
influenza pneumonia: a systematic review and meta-analysis |
Critical Care | Full Text. Accessed April 20, 2021.
https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2395-8
21. Consortium WST. Repurposed Antiviral Drugs for Covid-19 — Interim
WHO Solidarity Trial Results. New England Journal of Medicine .
Published online December 2, 2020. doi:10.1056/NEJMoa2023184
22. Li M, Yoo EJ, Baram M, et al. Tocilizumab in the Management of
COVID-19: A Preliminary Report. The American Journal of the
Medical Sciences . 2021;361(2):208-215. doi:10.1016/j.amjms.2020.11.005
23. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane
oxygenation support in COVID-19: an international cohort study of the
Extracorporeal Life Support Organization registry. The Lancet .
2020;396(10257):1071-1078. doi:10.1016/S0140-6736(20)32008-0
24. Schmidt M, Hajage D, Lebreton G, et al. Extracorporeal membrane
oxygenation for severe acute respiratory distress syndrome associated
with COVID-19: a retrospective cohort study. The Lancet
Respiratory Medicine . 2020;8(11):1121-1131.
doi:10.1016/S2213-2600(20)30328-3
25. Haiduc AA, Alom S, Melamed N, Harky A. Role of extracorporeal
membrane oxygenation in COVID-19: A systematic review. Journal of
Cardiac Surgery . 2020;35(10):2679-2687.
doi:https://doi.org/10.1111/jocs.14879
26. Shaheen A, Tanaka D, Cavarocchi NC, Hirose H. Veno-Venous
Extracorporeal Membrane Oxygenation (V V ECMO): Indications,
Preprocedural Considerations, and Technique. J Card Surg .
2016;31(4):248-252. doi:10.1111/jocs.12690
27. Sultanian P, Lundgren P, Strömsöe A, et al. Cardiac arrest in
COVID-19: characteristics and outcomes of in- and out-of-hospital
cardiac arrest. A report from the Swedish Registry for Cardiopulmonary
Resuscitation. European Heart Journal . 2021;42(11):1094-1106.
doi:10.1093/eurheartj/ehaa1067
28. Hirose H, Pitcher HT, Baram M, Cavarocchi NC. Issues in the
Intensive Care Unit for Patients with Extracorporeal Membrane
Oxygenation. Crit Care Clin . 2017;33(4):855-862.
doi:10.1016/j.ccc.2017.06.007
29. Awsare B, Herman J, Baram M. Management Strategies for Severe
Respiratory Failure: As Extracorporeal Membrane Oxygenation Is Being
Considered. Critical Care Clinics . 2017;33(4):795-811.
doi:10.1016/j.ccc.2017.06.003
30. Schmidt M, Stewart C, Bailey M, et al. Mechanical Ventilation
Management During Extracorporeal Membrane Oxygenation for Acute
Respiratory Distress Syndrome: A Retrospective International Multicenter
Study*. Critical Care Medicine . 2015;43(3):654-664.
doi:10.1097/CCM.0000000000000753
31. Blazoski C, Baram M, Hirose H. Outcomes of extracorporeal membrane
oxygenation in acute respiratory distress syndrome due to COVID-19: The
lessons learned from the first wave of COVID-19. Journal of
Cardiac Surgery . n/a(n/a). doi:https://doi.org/10.1111/jocs.15512
32. Acosta MAT, Singer BD. Pathogenesis of COVID-19-induced ARDS:
implications for an ageing population. European Respiratory
Journal . 2020;56(3). doi:10.1183/13993003.02049-2020
33. Cates J, Lucero-Obusan C, Dahl RM, et al. Risk for In-Hospital
Complications Associated with COVID-19 and Influenza — Veterans Health
Administration, United States, October 1, 2018–May 31, 2020. MMWR
Morb Mortal Wkly Rep . 2020;69(42):1528-1534. doi:10.15585/mmwr.mm6942e3
34. Wu C-P, Adhi F, Highland K. Recognition and management of
respiratory co-infection and secondary bacterial pneumonia in patients
with COVID-19. CCJM . 2020;87(11):659-663.
doi:10.3949/ccjm.87a.ccc015
35. Dudoignon E, Caméléna F, Deniau B, et al. Bacterial Pneumonia in
COVID-19 Critically Ill Patients: A Case Series. Clinical
Infectious Diseases . 2021;72(5):905-906. doi:10.1093/cid/ciaa762
36. Sharifipour E, Shams S, Esmkhani M, et al. Evaluation of bacterial
co-infections of the respiratory tract in COVID-19 patients admitted to
ICU. BMC Infectious Diseases . 2020;20(1):646.
doi:10.1186/s12879-020-05374-z
37. Vaillancourt M, Jorth P. The Unrecognized Threat of Secondary
Bacterial Infections with COVID-19. mBio . 2020;11(4).
doi:10.1128/mBio.01806-20
38. RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone
in Hospitalized Patients with Covid-19 - Preliminary Report. N
Engl J Med . Published online July 17, 2020. doi:10.1056/NEJMoa2021436
39. Guaraldi G, Meschiari M, Cozzi-Lepri A, et al. Tocilizumab in
patients with severe COVID-19: a retrospective cohort study. The
Lancet Rheumatology . 2020;2(8):e474-e484.
doi:10.1016/S2665-9913(20)30173-9